Platinumbased cancer drugs destroy tumor cells by binding to dna strands. In this randomised, openlabel, phase 2 study, adult patients with platinumsensitive, recurrent, highgrade serous ovarian cancer who had received up to three previous courses of platinumbased chemotherapy and who were progression free for at least 6 months before randomisation received either olaparib 200 mg capsules twice daily, administered orally on days 110 of each 21day cycle. The platinum compounds currently used in nsclc are cisplatin and carboplatin. Cisplatin, the oldest, has been approved as a cancer treatment since 1978. Treatment for colon cancer includes surgery, chemotherapy, and radiation therapy. Abstract platinumbased anticancer drugs are one of the most widely used drug classes in cancer therapy. Interest in platinum drugs has been revived recently. Platinumbased drugs cisplatin, carboplatin and oxaliplatin are widely used in the therapy of human neoplasms.
Download table platinumbased anticancer drugs used in the clinic from. Almost half of the chemotherapy regimens used today. Different treatments have been applied to kill cancer cells such as chemotherapy, which is the use of chemicals or drugs in order to treat cancer cells. Analysis of 17 trials that included 4,920 nsclc patients indicated that the platinumbased treatments are associated with a higher risk of anemia, nausea, and neurotoxicity p 0. Classic chemotherapy against crc is based on oxaliplatin and other cisplatin analogues. Platinum based cancer treatment linkedin slideshare. Screeningbased approach to discover effective platinumbased. The most widely used anticancer drugs are platinumbased. Why is platinum in some chemotherapy drugs, and can we. Platinumbased agents are important drugs or drug candidates for cancer chemotherapy.
The incidence, clinical manifestations, possible mechanisms of neurotoxicity, and management of neurotoxicities other than peripheral neuropathy with cisplatin, oxaliplatin, and the less. Platinumbased drugs are used to treat ovarian cancer, testicular cancer, and colon cancer. The resurgence of platinumbased cancer chemotherapy. They work by by slowing down the growth of cancer cells and killing them. Neoplasma the strength of the text lies in the diversity of topics that are covered in such a succinct fashion. Platinum based agents with respect to their structure, mechanism of action and strategies developed for improved efficacy in cancer treatment have been summarized in this paper with the perspective of developing new platinum drugs or platinum based therapy for individualized cancer treatment. Platinum based drugs cisplatin, carboplatin and oxaliplatin are widely used in the therapy of human neoplasms. Although the data for brca12related breast are therefore relatively limited, there are substantial data on the sensitivity of brca1related and brca2related ovarian cancers to platinumbased chemotherapy 7, 8. Platinum compounds produce changes in dna structure, which causes cancer cell death apoptosis. Platinum anticancer drugs are effective against a wide range of tumors, though their severe adverse effects and resistance remain unresolved. Eloxatin, 1r,2rcyclohexane1,2diamineethanedioatoo,oplatinumii formula. Costutility analysis of platinumbased chemotherapy. Thus, targeting hctr1 upregulation is an attractive strategy for. Their clinical success is, however, limited due to severe side effects and intrinsic or acquired resistance to the treatment.
Clearly, the use of platinum drugs is essential in the fight against cancer. Much effort has been put into the development of new platinum anticancer complexes, but none of them has reached worldwide clinical application so far. Platinumbased chemotherapeutics represent a mainstay of cancer therapy, but resistance limits their curative potential. Platinum neurotoxicity pharmacogenetics molecular cancer. Platinumbased chemotherapy in advanced nonsmallcell. A comparison of platinumbased and nonplatinumbased. Platinumbased agents for individualized cancer treatment.
Brca12related serous ovarian cancers are highly sensitive to platinum chemotherapy, and remain sensitive to repeat challenges with platinum chemotherapy, which likely. Platinumbased chemotherapy, with cytoreductive surgery, is the cornerstone of treatment of advanced ovarian cancer, however acquired drug resistance is a major clinical obstacle. During this time platinumbased drugs have made a major contribution to cancer therapy with significant benefits for many patients. Drug combination may be highly effective in recurrent. Fulltext platinumbased anticancer drugs encapsulated liposome. Western michigan university, 2015 cancer is considered the second leading cause of death after heart attack. Platinum and taxane combination is the recommended primary therapy for cancer stages ic to iv, while single agents may be administered depending on the platinum sensitivity of the tumor. Soprano and platinumbased drugs in cancer and chemoradiation in cancer therapy and nicholas p. Timely and interdisciplinary, platinumbased drugs in cancer therapy offers cancer therapeutics specialists an illuminating survey of every aspect of platinum drugs from mechanisms of action to toxicology, tumor resistance, and new analogs.
Through a kinome rnai screen, we identified microtubuleassociated serinethreonine kinase 1 mast1 as a main driver of cisplatin resistance in human cancers. Treatment of t24 bladder cancer cells with aqueous cddp loaded into. Clendeninn and krzyszt of and current strategies and edited andrew d. In addition, tumor resistance to oxaliplatin is related to. Overview platinum based therapy refers to a specific class chemotherapy drugs that are derived from the element platinum. Biological evaluation of phresponsive polymercaged nanobins for breast cancer therapy, acs nano, 10. Each drug is listed once at present, though it might fall in more than one subsection. However, the toxic side effects must be attenuated to reap the maximum benefits. A new era of metalbased drugs started in the 1960s, heralded by the discovery of potent platinumbased complexes, commencing with cisplatin h. Platinum therapy is the use of platinum compounds, which are cell damaging agents, for the treatment of specific cancers, including testicular, ovarian, lung, bladder, and head and neck cancers.
Ovarian cancer stem cell like side populations are enriched following chemotherapy and overexpress ezh2. Traditional platinum drugs including the globally approved cisplatin. Although sal analogs showed less promising ic50 values than sal, they were identified as the antitumor agents that significantly overcome the resistance to platinumbased drugs in ovarian cancer, more potent than unmodified sal and commonly used anticancer drugs5fluorouracil, gemcitabine, and cisplatin. However, their applicability and efficacy are limited by drug resistance and adverse effects. This is a list of chemotherapeutic agents, also known as cytotoxic agents, that are known to be of use in chemotherapy for cancer. Used for many of the same cancers and in similar regimens to cisplatin. Based on these results, two phase 3 trials are being planned for platinumsensitive and platinumresistant ovarian cancer patients by one of ncis new national cancer trial network groups, the nrg oncology group formerly 3 cooperative groups. Targeting drug transport mechanisms for improving platinum. Platinum compounds are widely used in the treatment of numerous tumor types, such as ovarian, lung, testicular, and bladder cancer. We recently reported chemotherapy effectiveness results from a national study of 12,181 patients aged 65 years and older diagnosed with stages i to iv ovarian. The emergent platinum drugs of the futureorally active agents, the sterically hindered zd0473, and the polynuclear charged platinum bbr3464are also fully considered. In ovarian cancer approximately 50 percent of tumors are intrinsically resistant to. Platinumbased anticancer drugs used in the clinic download table.
Olaparib combined with chemotherapy for recurrent platinum. Synthesis of new platinumbased anticancer drugs yasser saud. Platinumbased drugs have become a mainstay of cancer therapy. Platinum ptbased antitumor agents remain important chemotherapeutic agents for treating many human malignancies. Cisplatin was first used for cancer therapy in the 1970s. Resistance to platinumbased chemotherapy is a major clinical problem giaccone, 2000. A breakthrough in these drawbacks could be achieved by using polymeric micelles, i. Pdf the side effects of platinumbased chemotherapy drugs. Platinumbased chemotherapy remains the standardofcare for most patients affected by advanced nonsmall cell lung cancer nsclc. The widespread use of platinum agents in the treatment of cancer began with the discovery of the antineoplastic activity of cisplatin by barnett rosenberg in the 1960s. Roughly 10 to 20 percent of all cancer patients get a prescription for a platinumbased drug, according to the national cancer institute. Despite the pervasiveness of platinum drugs in cancer.
Platinum compounds an overview sciencedirect topics. Mechanism evidencebased clinical decision support at. Elevated expression of the human highaffinity copper transporter 1 hctr1, resulting in enhanced pt drug transport into cells, has been shown to be associated with improved treatment efficacy. Timely and interdisciplinary, platinumbased drugs in cancer therapy offers cancer therapeutics specialists an illuminating survey of every aspect of platinum drugs from. Why certain ovarian cancers develop resistance to platinum.
Their clinical success is, however, limited due to severe side effects and intrinsic. Enhancing the effects of platinumbased anticancer drugs date. Due to the increasing incidence and high mortality associated with colorectal cancer crc, novel therapeutic strategies are urgently needed. Platinumbased chemotherapy regimens did not offer a statistically significant benefit in survival or overall tumour response compared with nonplatinumbased regimens. However, cumulative toxicities and the emergence of resistance limit the use of these drugs. The platinumbased drugs cisplatin, carboplatin and oxaliplatin are regularly prescribed in the treatment of cancer and while they are effective, their use is limited by their severe, doselimiting side effects also referred to as adverse effectsevents. Common drug classes used to treat colon cancer are egfr antagonists, folate analogues, kinase inhibitors, nucleoside metabolic inhibitors, platinumbased drugs, and vegf antibodies. However, platinumbased chemotherapy regimens did increase complete response rates, at the cost of higher adverse events including nausea and vomiting, anaemia and thrombocytopenia toxicity. Indeed, 36 of 75 anticancer treatment regimens listed in martindale drug reference book are platinumbased, while pt drugs are prescribed. The platinumbased drugs in cancer therapy appears to be a comprehensive book useful for scientist, medical oncologist and pharmacist seeking answer on specific questions concerning preclinical and clinical data of platinum drugs.
Doctors use platinum drugs to treat many kinds of cancer, both alone and in combination with other drugs. Pdf the platinumbased drugs cisplatin, carboplatin and oxaliplatin are regularly prescribed in the treatment of cancer and while they are effective. Platinumbased chemotherapy the institute of cancer. For use in combination with radiation therapy rt for the treatment of locally or regionally advanced squamous cell carcinoma of the head and neck scchn or as a single agent for the treatment of patients with recurrent or metastatic scchn for whom prior platinumbased therapy has failed. This article summarises the history of platinum agents in this field and indicates the current and possible future directions of. Researchers have now identified a way to enhance the in vitro. Platinum anticancer agents johnson matthey technology. Why certain ovarian cancers develop resistance to platinumbased chemotherapy. The clinical toxicology of the platinum drugs is a subject area concerned with the adverse effects caused by platinumbased cancer chemotherapeutic agents in patients at doses conventionally used in cancer therapy. Among the widely used anticancer drugs, the platinum compounds cisplatin and oxaliplatin are most commonly associated with various forms of neurotoxicity.
Overcoming resistance to platinumbased drugs in ovarian. Platinumbased drugs in cancer therapy cancer drug discovery and development. Platinum complexes as anticancer agents recent patents on anticancer drug discovery, 2006, vol. Ovarian cancer is difficult to treat, largely because tumours are often found late and develop resistance to initial treatment. Olaparib maintenance therapy in patients with platinum. Platinum compounds currently used are cisplatin, carboplatin and oxaliplatin, either used alone or in. The side effects of platinumbased chemotherapy drugs. Understanding and improving platinum anticancer drugs. Trans platinum complexes in cancer therapy anti cancer agents in medicinal chemistry, 2007, vol.
There are three major platinum based cancer treatment drugs these drugs are used to treat advanced forms of a variety of cancers including colon, lung, ovarian, head and neck cancers. It is now 20 years since the publication of the antitumour activity of platinum compounds by barnett rosenberg and his colleagues. In total, a cancer patient can experience any combin 2018 frontier and perspective articles. This channel is dedicated to students of chemistry, medicine, pharmacy, biology, physics, agriculture and other branches studying chemistry. This list is organized by type of agent, although the subsections are not necessarily definitive and are subject to revision. Platinum chemotherapy for brca1 related breast cancer. Polymeric micelles for targeted tumor therapy of platinum. Platinum based drugs have become a mainstay of cancer therapy.
904 687 1162 247 621 92 296 1321 129 457 1567 1401 494 1485 238 1024 986 1480 1164 410 1433 1085 1023 815 225 846 709 1027 1481 1134 1037 532 214 803 365 1325 942 1338 840 1062 950